Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 3 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Recs

0
Player Avatar alicat2008 (91.38) Submitted: 11/11/2008 6:34:36 PM : Outperform Start Price: $7.12 RIGL Score: -48.16

cheap cheap cheap... let's see how it goes

Featured Broker Partners


Advertisement